Literature DB >> 73953

Respiratory disease associated with practolol therapy.

A J Marshall, W K Eltringham, D W Barritt, J D Davies, D A Griffiths, L K Jackson, G Laszlo, A E Read.   

Abstract

Six patients who had surgical treatment for sclerosing peritonitis caused by practolol now have a respiratory disorder characterised by dyspnoea, extensive fibrotic pleural thickening, and lesions in the lung parenchyma. Respiratory disease appears to be a further feature of the practolol syndrome.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 73953     DOI: 10.1016/s0140-6736(77)92663-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  3 in total

1.  Search for late-onset side effects of practolol.

Authors:  J Barclay; L E Ramsay; J L Jay; A McQueen; A R Lorimer
Journal:  Br Med J       Date:  1978-08-19

2.  Pleural fibrosis after practolol therapy.

Authors:  D R Hall; J B Morrison; F R Edwards
Journal:  Thorax       Date:  1978-12       Impact factor: 9.139

3.  Chondritis associated with fatal intramural bronchial fibrosis.

Authors:  T Higenbottam; J Dixon
Journal:  Thorax       Date:  1979-08       Impact factor: 9.139

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.